about
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...
Read More
1064.04
22.53
(2.16%)
2.7M
XNYS Volume
XNYS 06 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Eli Lilly is on 13 Jan 2026 for the purpose of 44th Annual J.P. Morgan Healthcare Conference
See details
High Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Star
These stocks are bullish, strong in quality and technicals, but expensive in valuation. Investors need to be cautious
View Similar
Embed DVM
Eli Lilly Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..